Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03007134 · ClinicalTrials.gov registry record
Multicenter International Cross-Sectional Evaluation of Pulmonary Alveolar Proteinosis Trial
A clinical trial, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- 73
- Enrollment target
NCT03007134 is a clinical trial that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 73 participants.
The verdict
NCT03007134 has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- 73 participants
- Enrollment target
Study Summary
The purpose of this study is to (1) compare a technically improved assay with an existing assay used to measure serum anti-GM-CSF antibodies in stored serum samples previously obtained from patients diagnosed with either primary, secondary, congenital or idiopathic pulmonary alveolar proteinosis (PAP), other chronic diseases or disease-free, healthy individuals; (2) determine the prevalence and levels of anti-GM-CSF autoantibodies and (3) define the breadth of the autoimmune antibody responses in primary PAP patients from the United States, Japan, Australia, and Europe using previously collected serum samples; and (4) using a chart review approach, compare the clinical, radiologic and laboratory features of primary PAP patients to determine if differences exist among patients in these globally geographically distributed regions.
Interventions
- OTHER Retrospective Chart Review
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2007-07 |
| Est. Completion | 2011-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03007134
The ClinicalTrials.gov registry entry for NCT03007134 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Retrospective Chart Review is the first listed.
NCT03007134 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03007134 about?
NCT03007134 is a clinical study titled "Multicenter International Cross-Sectional Evaluation of Pulmonary Alveolar Proteinosis Trial". The purpose of this study is to (1) compare a technically improved assay with an existing assay used to measure serum anti-GM-CSF antibodies in stored serum samples previously obtained from patients diagnosed with either primary, secondary, congenital or idiopathic pulmonary alveolar proteinosis (PA...
What is the current status of trial NCT03007134?
This trial is currently completed. The enrollment target is 73 participants. The study started on 2007-07. Estimated completion is 2011-07.
What interventions are being tested in trial NCT03007134?
The interventions under investigation include: Retrospective Chart Review (OTHER).
Who is sponsoring clinical trial NCT03007134?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.